<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02923297</url>
  </required_header>
  <id_info>
    <org_study_id>CHRO-2014-05</org_study_id>
    <nct_id>NCT02923297</nct_id>
  </id_info>
  <brief_title>GALIG Gene Expression in Parkinson's Disease</brief_title>
  <acronym>GALIGPARK</acronym>
  <official_title>GALIG Gene Expression in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional d'Orléans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre de Biophysique Moléculaire Orléans</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Régional d'Orléans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson's disease (PD) is the most frequent neurodegenerative disorder after Alzheimer's
      disease. It is characterized by motor symptoms (rigidity, tremor, slowness of movements), and
      non-motor symptoms (neuropsychological, psychiatric, pain ...). Neuronal death initiates in
      the brainstem and extends progressively through the entire cortex. The processes leading to
      cell death are poorly understood. Pathological cells exhibit abnormal deposits, called Lewy
      bodies, which contain numerous proteins. A major constituent of these protein deposits is
      alpha-synuclein. It has recently been demonstrated, in the Laboratory of Molecular Biophysics
      of the CNRS (Scientific Research National Center) in Orleans, that α-synuclein interacts with
      Cytogaligin, a protein produced by the proapoptotic GALIG gene. Cytogaligin could thus be a
      factor regulating α-synuclein activity or aggregation. It is postulated that the level of
      expression of the GALIG gene is different in Parkinson's disease patients compared with
      control subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">June 30, 2015</completion_date>
  <primary_completion_date type="Actual">June 30, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RNA (ribonucleic acid) assay of GALIG gene</measure>
    <time_frame>Day 0</time_frame>
    <description>Only one assessment in the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>RNA (ribonucleic acid) assay of SNCA genes</measure>
    <time_frame>Day 0</time_frame>
    <description>Only one assessment in the study</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Parkinson's disease patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>blood sampling</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>blood sampling for determine and compare the expression patterns of GALIG gene</description>
    <arm_group_label>Parkinson's disease patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Parkinson's Disease according to the criteria of the UKPDBB (UK
             Parkinson's disease brain bank).

        Exclusion Criteria:

          -  Insane patient arriving without a third party.

          -  Patient with Parkinson's disease arising from another etiology.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Canan OZSANCAK, Ph</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR d'ORLEANS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHR d'ORLEANS</name>
      <address>
        <city>Orleans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Alieva AKh, Filatova EV, Karabanov AV, Illarioshkin SN, Slominsky PA, Shadrina MI. Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease. Parkinsons Dis. 2015;2015:294396. doi: 10.1155/2015/294396. Epub 2015 Sep 21.</citation>
    <PMID>26483988</PMID>
  </reference>
  <reference>
    <citation>Pinho R, Guedes LC, Soreq L, Lobo PP, Mestre T, Coelho M, Rosa MM, Gonçalves N, Wales P, Mendes T, Gerhardt E, Fahlbusch C, Bonifati V, Bonin M, Miltenberger-Miltényi G, Borovecki F, Soreq H, Ferreira JJ, F Outeiro T. Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles. PLoS One. 2016 Jun 20;11(6):e0157852. doi: 10.1371/journal.pone.0157852. eCollection 2016. Erratum in: PLoS One. 2017 Dec 28;12 (12 ):e0190552.</citation>
    <PMID>27322389</PMID>
  </reference>
  <reference>
    <citation>Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):955-60. Epub 2007 Jan 10.</citation>
    <PMID>17215369</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2016</study_first_posted>
  <last_update_submitted>March 24, 2017</last_update_submitted>
  <last_update_submitted_qc>March 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>parkinson</keyword>
  <keyword>alpha-synuclein</keyword>
  <keyword>GALIG</keyword>
  <keyword>quantitative PCR (polymerase chain reaction)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

